Outcome of Radiation Therapy in Urinary Bladder Squampus Cell Carcinoma

Outcome of Radical Radiation Therapy in Squampus Cell Carcinoma

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04815629

Enrollment

Registered

2021-03-25

Start date

2022-04-01

Completion date

2023-04-01

Last updated

2021-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Bladder Squamous Cell Carcinoma

Brief summary

Detection of distribution of clinico-pathological features of squamous cell carcinoma of urinary bladder and their relation to treatment outcome.

Interventions

RADIATIONRadiotherapy

Radiotion therapy squamous cell carcinoma in cancer bladder

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

1. age 18-70 . 2. histologically proved urinary bladder squamous cell carcinoma. 3. non-metastatic disease. 4. all patients who underwent radical treatment or bladder preserving approach. 5. patient with isolated urinary bladder carcinoma (no other or previous primary).

Exclusion criteria

1. age \< 18 , \> 70. 2. patient not documented having bladder squamous cell carcinoma by biopsy (cystoscopic or operative). 3. metastatic disease. 4. patient with synchronous or metachronous double primary

Design outcomes

Primary

Measure	Time frame	Description
Disease free survival	baseline	Disease free survival

Contacts

Primary ContactAya Anter Ali, master degree

antaraya333@gmail.com+201120516228

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026